Application and efficacy analysis of rituximab in the treatment of childhood primary nephrotic syndrome in Ningxia
ObjectiveRituximab (RTX) has been widely used for primary nephrotic syndrome (PNS) in children of frequent relapse or hormonal dependence. The authors applied RTX for childhood PNS in Ningxia for the first time and examined its efficacy.MethodsFrom January 1, 2020 to December 31, 2022, 7 PNS childre...
Main Authors: | Wu Yang, Xiao-e Wang, Jia-le Gu, Li-juan Ma, Bai-ge Su, Hui-jie Xiao, Yong Yao, Hong-wen Zhang |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Nephrology
2024-02-01
|
Series: | Linchuang shenzangbing zazhi |
Subjects: | |
Online Access: | http://www.lcszb.com/cn/article/doi/10.3969/j.issn.1671-2390.2024.02.003 |
Similar Items
-
Rituximab therapy for childhood onset idiopathic nephrotic syndrome: experience of a Portuguese tertiary center
by: Rita Gomes, et al.
Published: (2022-10-01) -
Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
by: Yiyun Song, et al.
Published: (2023-07-01) -
Rituximab use in the treatment of children with nephrotic syndrome
by: L.I. Vakulenko, et al.
Published: (2022-06-01) -
Rituximab treatment in children with difficult-to-treat nephrotic syndrome
by: Gönül Parmaksız
Published: (2022-06-01) -
Rituximab therapy in adults with steroid-dependent nephrotic syndrome
by: Hongzhen Zhong, et al.
Published: (2019-10-01)